Cargando…

The microbiome in non-alcoholic fatty liver disease: associations and implications

Detalles Bibliográficos
Autores principales:	Lin, Eugenia A., Barlow, Gillian M., Mathur, Ruchi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2014
Materias:	Clinical Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982640/ https://www.ncbi.nlm.nih.gov/pubmed/24733426

Ejemplares similares

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Microbial metabolites in non-alcoholic fatty liver disease
por: Zhou, Da, et al.
Publicado: (2019)

Coronavirus disease 2019 and non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?
por: Purssell, Huw, et al.
Publicado: (2021)

Type 2 Diabetes and the Microbiome
por: Barlow, Gillian M, et al.
Publicado: (2022)

The association of vitamin D deficiency with non-alcoholic fatty liver disease
por: Küçükazman, Metin, et al.
Publicado: (2014)

Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?
por: Nobili, Valerio, et al.
Publicado: (2016)

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
por: Houttu, Veera, et al.
Publicado: (2020)

Guava Leaf Extract Suppresses Fructose Mediated Non-Alcoholic Fatty Liver Disease in Growing Rats
por: Sharma, Prateek, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: leading the fight in primary care
por: Theodoreson, Mark D, et al.
Publicado: (2022)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
por: Jennison, Erica, et al.
Publicado: (2021)

Transcriptome changes in stages of non-alcoholic fatty liver disease
por: Aljabban, Jihad, et al.
Publicado: (2022)

Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease
por: Hao, Li, et al.
Publicado: (2020)

Position statement on the diagnosis and management of non-alcoholic fatty liver disease
por: Alswat, Khalid A., et al.
Publicado: (2019)

The small bowel microbiome changes significantly with age and aspects of the ageing process
por: Leite, Gabriela, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
por: Kumar, Ramesh, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications
por: Klujszo, Elzbieta H., et al.
Publicado: (2019)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
por: Martin, Katherine, et al.
Publicado: (2021)

Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics
por: Nagashimada, Mayumi, et al.
Publicado: (2021)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)

Oral Microbiome and Alzheimer’s Disease
por: Wan, Jason, et al.
Publicado: (2023)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Promotion and induction of liver cancer by gut microbiome-mediated modulation of bile acids
por: Jia, Baolei, et al.
Publicado: (2019)

Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients
por: Hu, Yanjin, et al.
Publicado: (2016)

Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
por: Al Danaf, Layal, et al.
Publicado: (2022)

Duodenal microbiome changes in postmenopausal women: effects of hormone therapy and implications for cardiovascular risk
por: Leite, Gabriela, et al.
Publicado: (2022)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Management of nonalcoholic fatty liver disease in the Middle East
por: Sanai, Faisal M, et al.
Publicado: (2020)

Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
por: Said, Imaad, et al.
Publicado: (2022)

Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome
por: Mayneris-Perxachs, Jordi, et al.
Publicado: (2021)

Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study
por: Ciećko-Michalska, Irena, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
por: Yu, Cheng-Wei, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper
por: Antonucci, Laura, et al.
Publicado: (2017)

Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
por: Tana, Claudio, et al.
Publicado: (2019)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hiia689tsnavib5ios8ofqqu5a